Scarica l'app Stockscreener
8.83
0.11%
0.010
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EVH Giù?
Forum
Previsione
Precedente Chiudi:
$8.82
Aprire:
$8.81
Volume 24 ore:
1.80M
Relative Volume:
0.73
Capitalizzazione di mercato:
$1.04B
Reddito:
$2.35B
Utile/perdita netta:
$-74.42M
Rapporto P/E:
-9.3936
EPS:
-0.94
Flusso di cassa netto:
$150.93M
1 W Prestazione:
-2.43%
1M Prestazione:
-4.33%
6M Prestazione:
-28.68%
1 anno Prestazione:
-62.12%
Intervallo 1D:
$8.53
$8.85
Intervallo di 1 settimana:
$8.53
$9.52
Portata 52W:
$8.23
$33.48
Evolent Health Inc Stock (EVH) Company Profile
Nome
Evolent Health Inc
Settore
Industria
Telefono
571-389-6000
Indirizzo
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Confronta EVH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
8.83 | 1.06B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
242.78 | 38.63B | 2.75B | 714.14M | 1.09B | 4.33 |
|
TEM
Tempus Ai Inc
|
65.49 | 10.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
98.23 | 7.82B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
52.56 | 11.11B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
39.34 | 6.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-03 | Reiterato | BTIG Research | Buy |
| 2024-11-08 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Aggiornamento | Truist | Hold → Buy |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-01 | Iniziato | Oppenheimer | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-10-16 | Iniziato | UBS | Buy |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2022-11-01 | Iniziato | Truist | Hold |
| 2022-07-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2021-11-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Ripresa | JP Morgan | Neutral |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-07-06 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Downgrade | Goldman | Buy → Neutral |
| 2020-06-02 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Ripresa | Leerink Partners | Outperform |
| 2018-06-04 | Iniziato | Piper Jaffray | Overweight |
| 2018-04-24 | Ripresa | JP Morgan | Neutral |
| 2017-09-20 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Iniziato | Robert W. Baird | Outperform |
| 2017-03-14 | Iniziato | Oppenheimer | Outperform |
| 2017-01-13 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Ripresa | JP Morgan | Overweight |
| 2016-08-05 | Reiterato | FBR Capital | Outperform |
| 2016-07-26 | Iniziato | Jefferies | Buy |
| 2016-07-13 | Reiterato | FBR Capital | Outperform |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
| 2016-01-06 | Iniziato | Canaccord Genuity | Buy |
| 2015-06-30 | Iniziato | Goldman | Buy |
| 2015-06-30 | Iniziato | JP Morgan | Overweight |
| 2015-06-30 | Iniziato | Leerink Partners | Outperform |
| 2015-06-30 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Evolent Health Inc Borsa (EVH) Ultime notizie
Evolent Health (EVH) Sees Analyst Reaffirm Buy Rating and $15 Pr - GuruFocus
Evolent Health (NYSE:EVH shareholders incur further losses as stock declines 15% this week, taking three-year losses to 68% - simplywall.st
Evolent Health (EVH) Receives Price Target Upgrade from UBS | EV - GuruFocus
Evolent Health, Inc. (NYSE:EVH) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolent Health (EVH), Verastem (VSTM) and Sight Sciences (SGHT) - The Globe and Mail
Evolent Health Inc. Earnings Call Highlights Growth and Expansion - TipRanks
Expert Outlook: Evolent Health Through The Eyes Of 9 Analysts - Benzinga
Evolent Health (EVH) Receives Price Target Upgrade from UBS | EVH Stock News - GuruFocus
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Evolent Health Q1 2025 slides: Revenue falls but company maintains full-year guidance - Investing.com Australia
UBS Adjusts Price Target on Evolent Health to $15 From $14, Maintains Buy Rating - marketscreener.com
Evolent Health (EVH) Receives Price Target Boost from UBS | EVH Stock News - GuruFocus
Evolent Health Surpasses Revenue Expectations Despite Sales Decline - IndexBox
Evolent Health Inc earnings missed by $0.02, revenue topped estimates - Investing.com India
Evolent Health, Inc. SEC 10-Q Report - TradingView
Evolent Health Inc (EVH) Q1 2025 Earnings Call Highlights: Strong Start with New Agreements and ... By GuruFocus - Investing.com Canada
Evolent Health Inc (EVH) Q1 2025 Earnings Call Highlights: Strong Start with New Agreements and ... - Yahoo Finance
Evolent Health Inc (EVH) Q1 2025 Earnings Call Highlights: Strong Start with New Agreements and AI Advancements - GuruFocus
Earnings call transcript: Evolent Health Q1 2025 misses EPS forecast, stock rises - Investing.com
Evolent Health: Q1 Earnings Snapshot - Norwalk Hour
Evolent Health Reports Strong Q1 2025 Growth - TipRanks
Evolent Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Evolent Health (EVH) Q1 Earnings Lag Estimates - Yahoo Finance
Evolent Health (NYSE:EVH) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Evolent Health (EVH) Reports Strong Q1 Revenue Surpassing Expectations | EVH Stock News - GuruFocus
Evolent Health Inc Reports Q1 2025: Revenue Surpasses Estimates at $483.65M, EPS Misses with $0.63 Loss - GuruFocus
Evolent Health Q1 2025 slides: Revenue falls but company maintains full-year guidance By Investing.com - Investing.com South Africa
Evolent Announces First Quarter 2025 Results - Stock Titan
What to Expect from Evolent Health Inc (EVH) Q1 2025 Earnings - Yahoo Finance
Wall Street Analysts Believe Evolent Health (EVH) Could Rally 53.33%: Here's is How to Trade - Yahoo Finance
Evolent Health (EVH) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
1 Unprofitable Stock Worth Investigating and 2 to Question - Yahoo Finance
Evolent Health to Participate in Upcoming Conferences - Seeking Alpha
Evolent Health, Inc. (NYSE:EVH) Receives $17.71 Consensus Target Price from Brokerages - MarketBeat
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks - Yahoo Finance
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks - The Globe and Mail
Evolent Health, Inc. to Release First Quarter 2019 Operating Results and Host Conference Call on Tuesday, May 7, 2019 - BioSpace
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors - The Malaysian Reserve
Evolent Health Nominates Shawn Guertin to Board - TipRanks
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors | EVH Stock News - GuruFocus
Evolent Names Shawn Guertin As New Independent Nominee For Election To Its Board Of Directors - marketscreener.com
Molina Healthcare, Encompass Health, RadNet, Evolent Health, and Ibotta Shares Are Falling, What You Need To Know - Yahoo Finance
Analysts’ Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) - The Globe and Mail
Evolent Health Inc Azioni (EVH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):